Le Lézard
Classified in: Ebola virus, Health, Covid-19 virus
Subject: MRR

Adhesive Bandages Market to Record a CAGR of 4.26%, Growing Number of Surgical Procedures to Drive Growth - Technavio


NEW YORK, Sept. 1, 2022 /PRNewswire/ -- The adhesive bandages market growth is driven by factors such as the growing number of surgical procedures. The prevalence of chronic diseases, such as diabetes, obesity, and cardiovascular diseases, is increasing across the world. Developed countries such as the US, Canada, the UK, Australia, France, and Germany are witnessing a continuous rise in the number of people diagnosed with such diseases owing to changes in lifestyles and eating habits. Diabetes can lead to complications and corrective surgeries if not managed properly. Adhesive bandages can be used for managing diabetic ulcers. Hence, with the rising prevalence of diabetes, the demand for adhesive bandages is expected to increase during the forecast period.

The adhesive bandages market size is expected to grow by USD 622.43 mn from 2021 to 2026. Moreover, the growth momentum of the market will accelerate at a CAGR of 4.26% during the forecast period.

Make confident decisions using the benchmarks and analysis provided by Technavio. Request a FREE PDF Sample Report

Adhesive Bandages Market: Key Trends

The growing demand for adhesive bandages from ambulatory surgical centers (ASCs) is one of the key trends in the market. Most developed countries such as the US, Canada, the UK, France, and Germany have ASCs, which have modern hospital facilities and offer same-day surgical care. ASCs help patients with cost-effective surgeries, which can be performed in shorter durations. The surgeries can be performed in fully equipped operating rooms. The quality of care delivered in ASCs is considered to be as good as in hospitals. This, in turn, will positively impact the adhesive bandages market growth during the forecast period.

Stay updated with the latest trends in the adhesive bandages market. View our FREE PDF Sample Report Now

Adhesive Bandages Market: Segmentation Analysis

This report segments the adhesive bandages market by product (medicated bandages and non-medicated bandages) and geography (North America, Europe, Asia, and Rest of World (ROW)).

North America will lead the adhesive bandages market during the forecast period. The growth of the region is driven by factors such as advanced healthcare infrastructure. Moreover, market growth in this region will be faster than the growth of the market in Rest of World (ROW). The US and Canada are the key countries for the adhesive bandages market in North America. Prominent vendors in the regional market include 3M Co., Johnson and Johnson Inc., and Cardinal Health Inc. These vendors are launching new and innovative products in the market to expand their market share.

The medicated bandages segment will be the largest revenue-generating product segment during the forecast period. Medicated bandages are also known as first-aid dressings and plasters and consist of an antiseptic solution. These bandages are used to treat superficial injuries, cuts, and bruises and absorb exudate. The medicated bandages segment of the global adhesive bandages market comprises medicated cohesive fabric bandages and medicated flexible fixation bandages. Medicated cohesive fabric bandages can be used to cover wounds. They are also used to provide support to injured muscles and joints. Medicated flexible fixation bandages are used to hold dressings, compresses, and pads in place. These factors will drive the growth of the adhesive bandages segment during the forecast period.

Learn about the contribution of each segment summarized in concise infographics and thorough descriptions. View a FREE PDF Sample Report

Related Reports

Surgical Dressing Market by Product and Geography - Forecast and Analysis 2022-2026

Disposable Hospital Supplies Market by Product and Geography - Forecast and Analysis 2021-2025

Adhesive Bandages Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 4.26%

Market growth 2022-2026

USD 622.43 million

Market structure

Fragmented

YoY growth (%)

3.75

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 40%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

3M Co., Argentum Medical LLC, B. Braun SE, Beiersdorf Aktiengesellschaft, Cardinal Health Inc., Coloplast AS, ConvaTec Group Plc, Dynarex Corp., Essity Aktiebolag, Goldwin Medicare Ltd., Integra Lifesciences Holdings Corp., Johnson and Johnson, Lohmann and Rauscher GmbH and Co. KG, Medline Industries Inc., Medtronic Plc, Milliken and Co., Molnlycke Health Care AB, Paul Hartmann AG, Smith and Nephew plc, and Triage Meditech Pvt. Ltd.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

2 Market Landscape

3 Market Sizing

4 Five Forces Analysis

5 Market Segmentation by Product

6 Customer Landscape

7 Geographic Landscape

8 Drivers, Challenges, and Trends

9 Vendor Landscape

10 Vendor Analysis

11 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio


These press releases may also interest you

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 17:15
Amgen and AstraZeneca today announced the results of the Phase 2a COURSE trial evaluating Tezspire® (tezepelumab-ekko) in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of baseline blood...

18 mai 2024
Emmy-winning actor and St. Louis native Jon Hamm took the stage Saturday, May 18, to offer words of wisdom to the newest graduates of Saint Louis University (SLU) during the University's spring commencement in St. Louis. ...

18 mai 2024
Nearly 900 undergraduates of the Class of 2024 celebrated their send-off from Bentley University in a very different way than their 2020 arrival amid the COVID-19 pandemic. The 105th undergraduate commencement ceremony was marked by maskless smiles,...

18 mai 2024
Gilead Sciences, Inc. , following the recent acquisition of CymaBay Therapeutics, Inc., today announced interim results from the ongoing ASSURE study demonstrating treatment with seladelpar, an investigational PPAR delta agonist, led to improvements...

18 mai 2024
Mirum Pharmaceuticals, Inc. today announced data presented during the 56th European Society for Paediatric, Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Annual Meeting which took place this week in Milan, Italy. Data from LIVMARLI®...



News published on and distributed by: